Polymyalgia rheumatic and chronic myelomonocytic leukemia

被引:0
|
作者
Delapierre, A. [1 ]
Nganoa, C. [2 ]
Maitre, E. [3 ]
Briet-Rochoux, Q. [1 ]
Maillot, F. [4 ,5 ]
Aouba, A. [6 ]
Audemard-Verger, A. [4 ,5 ]
机构
[1] CHU Caen, Serv Rhumatol, Ave Cote Nacre, F-14033 Caen 9, France
[2] CHU Caen, Serv Med Nucl, Ave Cote Nacre, F-14033 Caen 9, France
[3] CHU Caen, Serv Hematol Cellulaire, Ave Cote Nacre, F-14033 Caen 9, France
[4] CHRU Tours, Serv Med Interne & Immunol Clin, Tours, France
[5] Univ Tours, Tours, France
[6] CHU Caen, Serv Med Interne, Ave Cote Nacre, F-14033 Caen 9, France
来源
REVUE DE MEDECINE INTERNE | 2021年 / 42卷 / 06期
关键词
Polymyalgia rheumatica; Pericarditis; Chronic myelomonocytic leukemia; Myelodysplastic syndrome; Systemic inflammatory and autoimmune disease; MYELODYSPLASTIC SYNDROMES; AUTOIMMUNE MANIFESTATIONS;
D O I
10.1016/j.revmed.2020.08.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. - Myelodysplasia (MDS) can occur as systemic manifestations such as connective tissue diseases or vasculitis. Rheumatological manifestations are also described in such context. Herein, we report the observation of a patient with chronic myelomonocytic leukemia (CMML) who developed systemic manifestations: polymyalgia rheumatica and pericarditis. Case report. - A 78-year-old patient was referred for the exploration of two months history of inflammatory shoulder pain associated with biological inflammatory syndrome. He presented with asthenia, anorexia and loss of 5 kg in one month. He had a three years follow-up for a CMML without any specific treatment. All of the explorations carried out showed a typical polymyalgia rheumatica. A pericardial effusion requiring emergency drainage was synchronously diagnosed. All the symptoms occurred during a worsening of his hematological disease. The rheumatological manifestation was favorable after a short corticosteroid therapy and pericarditis did not recur after 2 years of follow-up. Conclusion. - It should be necessary to screen patients for MDS in a context of systemic manifestation, especially in elderly patients with an abnormal blood count (cytopenia, macrocytosis and monocytosis). (C) 2020 Societe Nationale Francaise de Medecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:434 / 437
页数:4
相关论文
共 50 条
  • [21] Chronic myelomonocytic leukemia.
    Bennett J.M.
    Current Treatment Options in Oncology, 2002, 3 (3) : 221 - 223
  • [22] Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia
    Geyer, Julia T.
    Tam, Wayne
    Liu, Yen-Chun
    Chen, Zhengming
    Wang, Sa A.
    Bueso-Ramos, Carlos
    Oak, Jean
    Arber, Daniel A.
    Hsi, Eric
    Rogers, Heesun J.
    Levinson, Katherine
    Bagg, Adam
    Hassane, Duane C.
    Hasserjian, Robert P.
    Orazi, Attilio
    MODERN PATHOLOGY, 2017, 30 (09) : 1213 - 1222
  • [23] Treatment of chronic myelomonocytic leukemia
    Burgstaller S.
    memo - Magazine of European Medical Oncology, 2016, 9 (4) : 168 - 171
  • [24] Chronic myelomonocytic leukemia in a cat
    Shimoda, T
    Shiranaga, N
    Mashita, T
    Hasegawa, A
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2000, 62 (02): : 195 - 197
  • [25] CHRONIC LYMPHOCYTIC-LEUKEMIA COEXISTING WITH CHRONIC MYELOMONOCYTIC LEUKEMIA
    FERRARA, F
    DELVECCHIO, L
    ANTONOLFI, I
    MELE, G
    RAMETTA, V
    CIMINO, R
    HAEMATOLOGICA, 1992, 77 (02) : 171 - 173
  • [26] Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined
    Elliot, Michelle A.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2006, 19 (03) : 571 - 593
  • [27] Chronic urticaria associated with chronic myelomonocytic leukemia
    Alonso, R
    Cisteró-Bahíma, A
    Enrique, E
    Besses, C
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY, 2000, 10 (06): : 380 - 381
  • [28] Contemporary Risk Stratification and Treatment of Chronic Myelomonocytic Leukemia
    Tremblay, Douglas
    Rippel, Noa
    Feld, Jonathan
    El Jamal, Siraj M.
    Mascarenhas, John
    ONCOLOGIST, 2021, 26 (05): : 406 - 421
  • [29] Erythema nodosum and chronic myelomonocytic leukemia: two cases
    Bolla, G
    Lambert, M
    Boscagli, A
    Frippiat, F
    Vandercam, B
    Montagne, N
    Puchois, A
    REVUE DE MEDECINE INTERNE, 1998, 19 (11): : 838 - 839
  • [30] Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia
    Invernizzi, R
    Travaglino, E
    Benatti, C
    Malcovati, L
    Della Porta, M
    Cazzola, M
    Ascari, E
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 76 (06) : 494 - 501